These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27770343)

  • 1. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
    Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
    Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
    Kanda M; Shimizu D; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncotarget; 2016 Mar; 7(12):13667-79. PubMed ID: 26872374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of sushi domain containing two reflects the malignant potential of gastric cancer.
    Umeda S; Kanda M; Miwa T; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Cancer Med; 2018 Oct; 7(10):5194-5204. PubMed ID: 30259711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer.
    Baba H; Kanda M; Sawaki K; Umeda S; Miwa T; Shimizu D; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y; Fujii T
    Ann Surg Oncol; 2020 Jun; 27(6):2071-2080. PubMed ID: 31659640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
    Kanda M; Nomoto S; Oya H; Hashimoto R; Takami H; Shimizu D; Sonohara F; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Murotani K; Fujiwara M; Kodera Y
    J Exp Clin Cancer Res; 2014 Oct; 33(1):88. PubMed ID: 25330808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer.
    Fujiya K; Terashima M; Ohshima K; Aizawa D; Sugino T; Serizawa M; Nakamura K; Nagashima T; Hatakeyama K; Urakami K; Akiyama Y; Tsubosa Y; Kitagawa Y; Yamaguchi K
    Gastric Cancer; 2021 Mar; 24(2):341-351. PubMed ID: 32965606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.
    Shimizu D; Kanda M; Tanaka H; Kobayashi D; Tanaka C; Hayashi M; Iwata N; Niwa Y; Takami H; Yamada S; Fujii T; Nakayama G; Fujiwara M; Kodera Y
    Sci Rep; 2017 Feb; 7():42089. PubMed ID: 28165032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.
    Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.
    Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y
    Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
    Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
    Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.
    Miwa T; Kanda M; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Koike M; Kodera Y
    Ann Surg Oncol; 2019 May; 26(5):1535-1543. PubMed ID: 30673899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
    Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
    Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China.
    Liu Q; Bi JJ; Tian YT; Feng Q; Zheng ZX; Wang Z
    Asian Pac J Cancer Prev; 2015; 16(4):1665-9. PubMed ID: 25743789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy.
    Wang SY; Yeh CN; Lee HL; Liu YY; Chao TC; Hwang TL; Jan YY; Chen MF
    Ann Surg Oncol; 2009 Oct; 16(10):2738-43. PubMed ID: 19636636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.